Table 2.

Clinical Characteristics Associated with the Expression of E-Cadherin and N-Cadherin

Clinicopathologic Factors	n	E-Cadherin		p	N-Cadherin		p
Positive (%)	Negative (%)	Positive (%)	Negative (%)
Gender
Male	75	39(52.00)	36(48.00)	0.179	41(54.66)	34(45.34)	0.428
Female	5	1(20.00)	4(80.00)	2(40.00)	3(60.00)
Age
≥60	54	30(55.55)	24(44.45)	0.833	30(55.55)	24(44.45)	0.409
<60	26	10(38.46)	16(61.36)	13(50.00)	13(50.00)
Differentiation
Well and moderate	67	35(52.23)	32(47.77)	0.273	31(46.62)	36(63.38)	0.112
Poor	13	5(38.46)	8(61.52)	9(69.23)	4(30.76)
Tumor stage
Ⅰ+Ⅱ	51	31(60.79)	20(39.21)	0.021*	24(47.05)	27(52.95)	0.004*
Ⅲ+Ⅳ	29	10(34.49)	19(65.51)	23(79.31)	6(20.68)
Response
Radiosensitive	46	29(63.04)	17(36.96)	0.006*	18(39.13)	28(60.87)	0.002*
Radioresistance	34	11(32.35)	23(67.65)	25(73.52)	9(26.48)

Note: *p<0.05.